From: Health News Review
Andrew Holtz
News releases on studies should put the evidence they report in context. But how do you judge a release when there isn’t enough… evidence, that is?
In April, the US Centers for Disease Control and Prevention (CDC) announced youth tobacco survey results with this headline and subhead:
E-cigarette use triples among middle and high school students in just one year
***
From: GoUpstate.com
By Allison M. Roberts
Right now, there are no regulations on the e-cigarette industry because organizations such as the Food and Drug Administration, and the Centers for Disease Control and Prevention still know very little about the long-term effects of e-cigarette use — also known as vaping.
In 2009, President Barack Obama signed the Family Smoking Prevention and Tobacco Control Act. Under the act, the FDA is permitted to regulate cigarettes, cigarette tobacco, roll-your-own-tobacco and smokeless tobacco.
From: Oregon Live
By Joe Nocera
“We need a national debate on nicotine,” said Mitch Zeller.
Zeller is the director of the Center for Tobacco Products, a division of the Food and Drug Administration created in 2009 when Congress passed legislation giving the FDA regulatory authority – at long last! – over cigarettes. In addition, the center will soon have regulatory authority over other tobacco products, including electronic cigarettes, which have become enormously controversial even as they have gained in use. Through something called a “deeming rule,” the center is in the process of asserting that oversight over e-cigarettes.
From: Heartlander
U.S. Food and Drug Administration (FDA) Acting Commissioner Dr. Stephen Ostroff announced the agency’s intention to proceed “full steam ahead” on regulations intended to reduce e-cigarette use.
Ostroff says FDA intends to enact a “deeming rule” expanding the agency’s regulation of tobacco products to include e-cigarettes, which do not contain tobacco.
From: CSPnet.com
By Melissa Vonder Haar, Tobacco Editor
WASHINGTON — Andrew Perraut has a unique view on the U.S. Food and Drug Administration’s (FDA) rulemaking process, especially when it comes to deeming: asa policy analyst for the White House Office of Information and Regulatory Affairs (OIRA), Perraut was the lead for all regulatory issues for tobacco for six years (pre-dating the FDA’s Center for Tobacco Products) and participated in the redrafting of the deeming regulations before the proposed regs went public in April 2014.
***
